Background/Aims: Recently, we reported that small renal arteries, defined by a low reference diameter (RD) or minimal luminal diameter (MD), are independently associated with a low GFR, resistant hypertension, and onset of contrast-induced nephropathy and suggested a post-hoc analysis of CORAL trial based on RD categories. Here we hypothesized that RD and MD are markers of nontraditional cardiovascular risk factors and tested whether low RD and MD could impact the prognosis of patients with ischemic heart disease. Methods: Prospective cohort study. We used proportional hazards models to analyze the first onset of cardiovascular events in relation with RD, MD, or percentage of renal artery stenosis (RAS) in those with low-to-moderate RAS (10-70%) (n = 181). Results: During the median follow-up of 4.5 (range, 0.1-5) years, 27.8% participants (n = 623; mean age, 64 years; 29% women) experienced a cardiovascular event (35.4% in those with RAS 10-70%). The presence of low-to-moderate RAS was associated with cardiovascular events. In these subjects, those with low MD were associated with a higher risk of cardiovascular events (MD >4.2 mm, HR: 1; MD 3.2-4.2 mm, HR: 1.66, 95% CI: 0.74-3.72, p = 0.22; MD <3.2 mm, HR: 3.72, 95% CI: 1.65-8.40, p = 0.002). When MD was added to a standard risk-factor model, risk prediction improvement was by 4.1%. Results were qualitatively similar if MD was replaced by RD or percentage of stenosis, but with smaller improvement of risk prediction and model fit. Conclusions: In patients with ischemic heart disease and low-to-moderate RAS, MD is a significant predictor of cardiovascular events, improves risk prediction, and may represent a valuable biomarker of cardiovascular disease risk. i 2014 S. Karger AG, Basel

Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC, Ishani A, Collins AJ, Foley RN: Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005;68:293-301.
Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O'Donoghue DJ, Waldek S, Kalra PA: Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002;13:149-157.
Guo H, Kalra PA, Gilbertson DT, Liu J, Chen SC, Collins AJ, Foley RN: Atherosclerotic renovascular disease in older US patients starting dialysis, 1996-2001. Circulation 2007;115:50-58.
Langille BL, O'Donnell F: Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium dependent. Science 1986;231:405-407.
Khawaja Z, Wilcox CS: Role of the kidneys in resistant hypertension. Int J Hypertens 2011;2011:143471.
Langille BL: Remodelling of developing and mature arteries: endothelium, smooth muscle, and matrix. J Cardiovasc Pharmacol 1993;21:S11-S17.
Zanoli L, Rastelli S, Marcantoni C, Blanco J, Capodanno D, Tamburino C, Castellino P: Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular risk. Nephron Extra 2011;1:38-44.
Zanoli L, Rastelli S, Marcantoni C, Tamburino C, Laurent S, Boutouyrie P, Castellino P: Renal artery diameter, renal function and resistant hypertension in patients with low-to-moderate renal artery stenosis. J Hypertens 2012;30:600-607.
Yu H, Zhang D, Haller S, Kanjwal K, Colyer W, Brewster P, Steffes M, Shapiro JI, Cooper CJ: Determinants of renal function in patients with renal artery stenosis. Vasc Med 2011;16:331-338.
Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS: Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002;105:1354-1359.
Marcantoni C, Zanoli L, Rastelli S, Tripepi G, Matalone M, Di Landro D, Scandura S, Tamburino C, Zoccali C, Castellino P: Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized trial. J Nephrol 2009;22:13-16.
Marcantoni C, Rastelli S, Zanoli L, Tripepi G, Di Salvo M, Monaco S, Sgroi C, Capodanno D, Tamburino C, Castellino P: Erratum to: Prevalence of renal artery stenosis in patients undergoing cardiac catheterization. Intern Emerg Med 2013;8:401-408.
Levey AS, Stevens LA: Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 2010;55:622-627.
Capodanno D, Marcantoni C, Ministeri M, Dipasqua F, Zanoli L, Rastelli S, Mangiafico S, Sanfilippo M, Romano G, Tamburino C: Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention. Int J Cardiol 2013;168:396-402.
Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ: Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010;121:505-511.
Conlon PJ, Athirakul K, Kovalik E, Schwab SJ, Crowley J, Stack R, McCants CB Jr, Mark DB, Bashore TM, Albers F: Survival in renal vascular disease. J Am Soc Nephrol 1998;9:252-256.
Marcantoni C, Zanoli L, Rastelli S, Tripepi G, Matalone M, Mangiafico S, Capodanno D, Scandura S, Di Landro D, Tamburino C, Zoccali C, Castellino P: Effect of renal artery stenting on left ventricular mass: a randomized clinical trial. Am J Kidney Dis 2012;60:39-46.
ASTRAL Investigators; Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J: Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953-1962.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators: Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014;370:13-22.
Zanoli L, Marcantoni C, Castellino P: Stenting for renal-artery stenosis. N Engl J Med 2014;370:1854.
Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, SchFmig A: Vessel size and long-term outcome after coronary stent placement. Circulation 1998;98:1875-1880.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.